Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Two-period microdosing pharmacokinetic study of oral and intravenous ITMN-8187 in healthy volunteers
NL-OMON34901Active, not recruiting
- Sponsor
- InterMune
- Start
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ITMN-8187 in hepatitis C virus infection, sponsored by InterMune. Primary endpoints: Pharmacokinetics of parent drug, Pharmacokinetics of total radioactivity and 1 more. Started Feb 2010; status: active, not recruiting.
02
Drugs
ITMN-8187
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NL-OMON34901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34901.